603079 圣达生物
已收盘 02-13 15:00:00
资讯
新帖
简况
每周股票复盘：圣达生物（603079）闲置募资到期赎回获收益31.16万元
证券之星 · 02-15
每周股票复盘：圣达生物（603079）闲置募资到期赎回获收益31.16万元
每周股票复盘：圣达生物（603079）使用8000万元闲置募集资金购买结构性存款
证券之星 · 02-08
每周股票复盘：圣达生物（603079）使用8000万元闲置募集资金购买结构性存款
圣达生物（603079）披露使用闲置募集资金进行现金管理的进展公告，2月6日股价下跌0.25%
证券之星 · 02-06
圣达生物（603079）披露使用闲置募集资金进行现金管理的进展公告，2月6日股价下跌0.25%
每周股票复盘：圣达生物（603079）大股东拟减持不超3%股份
证券之星 · 02-01
每周股票复盘：圣达生物（603079）大股东拟减持不超3%股份
圣达生物（603079）披露大股东减持股份计划公告，1月26日股价下跌0.61%
证券之星 · 01-26
圣达生物（603079）披露大股东减持股份计划公告，1月26日股价下跌0.61%
每周股票复盘：圣达生物（603079）2025年净利预增69.93%至120.90%
证券之星 · 01-25
每周股票复盘：圣达生物（603079）2025年净利预增69.93%至120.90%
股市必读：圣达生物（603079）预计2025年全年归属净利润盈利5000万元至6500万元
证券之星 · 01-23
股市必读：圣达生物（603079）预计2025年全年归属净利润盈利5000万元至6500万元
圣达生物(603079.SH)发预增，预计2025年归母净利润5000万元至6500万元，增长69.93%至120.9%
智通财经 · 01-22
圣达生物(603079.SH)发预增，预计2025年归母净利润5000万元至6500万元，增长69.93%至120.9%
每周股票复盘：圣达生物（603079）完成取消监事会工商变更
证券之星 · 01-18
每周股票复盘：圣达生物（603079）完成取消监事会工商变更
每周股票复盘：圣达生物（603079）变更签字注册会计师
证券之星 · 01-02
每周股票复盘：圣达生物（603079）变更签字注册会计师
圣达生物（603079）披露关于变更签字注册会计师的公告，12月29日股价下跌1.3%
证券之星 · 2025-12-29
圣达生物（603079）披露关于变更签字注册会计师的公告，12月29日股价下跌1.3%
圣达生物（603079）披露使用闲置募集资金进行现金管理进展公告，12月26日股价下跌2.13%
证券之星 · 2025-12-26
圣达生物（603079）披露使用闲置募集资金进行现金管理进展公告，12月26日股价下跌2.13%
圣达生物（603079）1784.07万股限售股将于12月25日解禁，占总股本9.44%
证券之星 · 2025-12-25
圣达生物（603079）1784.07万股限售股将于12月25日解禁，占总股本9.44%
圣达生物（603079）披露向特定对象发行股票限售股上市流通公告，12月18日股价上涨0.31%
证券之星 · 2025-12-18
圣达生物（603079）披露向特定对象发行股票限售股上市流通公告，12月18日股价上涨0.31%
圣达生物宣布9.4%股份锁定期将结束，股票将于12月25日开始交易
美股速递 · 2025-12-18
圣达生物宣布9.4%股份锁定期将结束，股票将于12月25日开始交易
圣达生物（603079）披露使用闲置募集资金进行现金管理进展公告，12月12日股价下跌0.3%
证券之星 · 2025-12-12
圣达生物（603079）披露使用闲置募集资金进行现金管理进展公告，12月12日股价下跌0.3%
圣达生物（603079）披露召开2025年第四次临时股东大会通知，11月27日股价上涨1.29%
证券之星 · 2025-11-27
圣达生物（603079）披露召开2025年第四次临时股东大会通知，11月27日股价上涨1.29%
每周股票复盘：圣达生物（603079）使用5000万元闲置募资购买结构性存款
证券之星 · 2025-11-09
每周股票复盘：圣达生物（603079）使用5000万元闲置募资购买结构性存款
异动快报：圣达生物（603079）11月5日9点44分触及涨停板
证券之星 · 2025-11-05
异动快报：圣达生物（603079）11月5日9点44分触及涨停板
圣达生物（603079）披露使用闲置募集资金进行现金管理进展，11月04日股价上涨0.05%
证券之星 · 2025-11-04
圣达生物（603079）披露使用闲置募集资金进行现金管理进展，11月04日股价上涨0.05%
加载更多
公司概况
公司名称：
浙江圣达生物药业股份有限公司
所属行业：
食品制造业
上市日期：
2017-08-23
主营业务：
浙江圣达生物药业股份有限公司的主营业务是维生素、生物保鲜剂、食品添加剂和饲料添加剂的研发、生产和销售，并涉足功能配料领域。公司的主要产品是生物素、叶酸等维生素类产品和乳酸链球菌素、纳他霉素、聚赖氨酸、蔗糖发酵物等生物保鲜剂及功能配料产品。
发行价格：
15.09
{"stockData":{"symbol":"603079","market":"SH","secType":"STK","nameCN":"圣达生物","latestPrice":19.82,"timestamp":1770966001000,"preClose":19.27,"halted":0,"volume":3800187,"delay":0,"changeRate":0.0285,"floatShares":189000000,"shares":189000000,"eps":0.3232,"marketStatus":"已收盘","change":0.55,"latestTime":"02-13 15:00:00","open":19.45,"high":20.13,"low":19.23,"amount":75366200,"amplitude":0.0467,"askPrice":19.82,"askSize":39,"bidPrice":19.81,"bidSize":110,"shortable":0,"etf":0,"ttmEps":0.3232,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":19.27,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":21.2,"lowLimit":17.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":189029624,"isCdr":false,"pbRate":2.38,"roa":"--","peRate":61.324257,"roe":"3.88%","epsLYR":0.17,"committee":0.495396,"marketValue":3747000000,"turnoverRate":0.0201,"status":0,"floatMarketCap":3747000000},"requestUrl":"/m/hq/s/603079","defaultTab":"news","newsList":[{"id":"2611458361","title":"每周股票复盘：圣达生物（603079）闲置募资到期赎回获收益31.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611458361","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611458361?lang=zh_cn&edition=full","pubTime":"2026-02-15 01:50","pubTimestamp":1771091423,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，圣达生物报收于19.82元，较上周的19.89元下跌0.35%。本周，圣达生物2月9日盘中最高价报20.99元。圣达生物当前最新总市值37.47亿元，在化学制品板块市值排名133/170，在两市A股市值排名4237/5189。公司公告汇总浙江圣达生物药业股份有限公司于2025年12月11日使用闲置募集资金10,000.00万元购买中国建设银行浙江省分行单位人民币定制型结构性存款产品，产品期限为62天，起息日为2025年12月12日，到期日为2026年2月12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603079","BK0191","BK0226"],"gpt_icon":0},{"id":"2609152502","title":"每周股票复盘：圣达生物（603079）使用8000万元闲置募集资金购买结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2609152502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609152502?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:33","pubTimestamp":1770489190,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，圣达生物报收于19.89元，较上周的20.37元下跌2.36%。本周，圣达生物2月3日盘中最高价报20.7元。圣达生物当前最新总市值37.6亿元，在化学制品板块市值排名132/170，在两市A股市值排名4237/5186。本周关注点公司公告汇总：圣达生物使用8,000.00万元闲置募集资金购买中国建设银行单位人民币定制型结构性存款。最近12个月已累计使用18,000.00万元额度，尚余5,000.00万元可用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603079","BK0226"],"gpt_icon":0},{"id":"2609359438","title":"圣达生物（603079）披露使用闲置募集资金进行现金管理的进展公告，2月6日股价下跌0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609359438","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609359438?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:19","pubTimestamp":1770387555,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，圣达生物报收于19.89元，较前一交易日下跌0.25%，最新总市值为37.6亿元。该股当日开盘19.94元，最高20.26元，最低19.81元，成交额达4370.74万元，换手率为1.16%。近日，浙江圣达生物药业股份有限公司发布《关于使用闲置募集资金进行现金管理的进展公告》。公告显示，公司使用闲置募集资金8,000.00万元购买中国建设银行浙江省分行单位人民币定制型结构性存款，产品期限42天，为保本浮动收益型，不影响募投项目实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600041025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0226","603079"],"gpt_icon":0},{"id":"2608706600","title":"每周股票复盘：圣达生物（603079）大股东拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608706600","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608706600?lang=zh_cn&edition=full","pubTime":"2026-02-01 04:05","pubTimestamp":1769889911,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，圣达生物报收于20.37元，较上周的21.41元下跌4.86%。本周，圣达生物1月26日盘中最高价报21.6元。本周关注点公司公告汇总：5%以上大股东拟减持不超3%股份，因资金规划需要。因资金规划需要，万健投资拟于2026年2月25日至2026年5月24日期间，通过集中竞价和大宗交易方式减持公司股份不超过5,670,888股，减持比例不超过公司总股本的3%。万健投资及其一致行动人合计持有公司股份90,225,545股，占总股本47.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0226","603079"],"gpt_icon":0},{"id":"2606424927","title":"圣达生物（603079）披露大股东减持股份计划公告，1月26日股价下跌0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606424927","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606424927?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:55","pubTimestamp":1769439351,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，圣达生物报收于21.28元，较前一交易日下跌0.61%，最新总市值为40.23亿元。近日，浙江圣达生物药业股份有限公司发布《股东减持股份计划公告》。公告显示，公司5%以上大股东天台万健投资发展中心持有公司股份28,737,470股，占公司总股本的15.20%。万健投资及其一致行动人合计持有公司股份90,225,545股，占总股本47.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600036998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603079","BK0226"],"gpt_icon":0},{"id":"2606523227","title":"每周股票复盘：圣达生物（603079）2025年净利预增69.93%至120.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606523227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606523227?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:05","pubTimestamp":1769281512,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，圣达生物报收于21.41元，较上周的20.15元上涨6.25%。本周，圣达生物1月21日盘中最高价报22.0元，股价触及近一年最高点。本周关注点业绩披露要点：圣达生物预计2025年净利同比增长69.93%至120.90%。公司公告汇总：圣达生物拟计提资产减值准备合计约915.00万元。圣达生物发布业绩预告，预计2025年全年扣非后净利润盈利4300万元至5800万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0226","603079"],"gpt_icon":0},{"id":"2605416104","title":"股市必读：圣达生物（603079）预计2025年全年归属净利润盈利5000万元至6500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605416104","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605416104?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:37","pubTimestamp":1769103429,"startTime":"0","endTime":"0","summary":"业绩披露要点业绩预告圣达生物发布业绩预告，预计2025年全年归属净利润盈利5000万元至6500万元；扣非后净利润盈利4300万元至5800万元。公司公告汇总浙江圣达生物药业股份有限公司2025年年度业绩预增公告浙江圣达生物药业股份有限公司预计2025年年度实现归属于母公司所有者的净利润为5,000.00万元至6,500.00万元，同比增长69.93%至120.90%；扣除非经常性损益后的净利润为4,300.00万元至5,800.00万元，同比增长91.42%至158.19%。本次计提将减少公司2025年度归属于上市公司股东净利润915.00万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300000835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603079"],"gpt_icon":0},{"id":"2605463686","title":"圣达生物(603079.SH)发预增，预计2025年归母净利润5000万元至6500万元，增长69.93%至120.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605463686","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605463686?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:42","pubTimestamp":1769067744,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣达生物(603079.SH)披露2025年年度业绩预增公告，公司预计2025年年度实现归属于母公司所有者的净利润为5000万元至6500万元，同比增长69.93%至120.90%。预计2025年年度实现归属于母公司所有者的扣除非经常性损益的净利润为4300万元至5800万元，同比增长91.42%至158.19%。报告期内，公司通过持续推动精细化管理与技术升级，进一步优化了运营效率与成本结构。同时，公司深化差异化竞争战略，加大市场拓展力度，抓住市场机会，推动了公司整体盈利能力的提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396092.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"圣达生物(603079.SH)发预增，预计2025年归母净利润5000万元至6500万元，增长69.93%至120.9%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603079"],"gpt_icon":0},{"id":"2604925878","title":"每周股票复盘：圣达生物（603079）完成取消监事会工商变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925878?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:34","pubTimestamp":1768678449,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，圣达生物报收于20.15元，较上周的18.3元上涨10.11%。本周，圣达生物1月16日盘中最高价报21.31元。本周关注点公司公告汇总：圣达生物完成取消监事会、修改章程及工商变更登记，注册资本为189,029,624元。公司公告汇总浙江圣达生物药业股份有限公司于2025年11月27日和12月15日分别召开第四届董事会第二十一次会议及2025年第四次临时股东大会，审议通过取消监事会、修改《公司章程》并办理工商变更登记等相关议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603079","BK0226","BK0191"],"gpt_icon":0},{"id":"2600035046","title":"每周股票复盘：圣达生物（603079）变更签字注册会计师","url":"https://stock-news.laohu8.com/highlight/detail?id=2600035046","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600035046?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:33","pubTimestamp":1767292389,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，圣达生物报收于16.98元，较上周的16.71元上涨1.62%。本周，圣达生物12月24日盘中最高价报17.58元。本周关注点公司公告汇总：圣达生物变更2025年度签字注册会计师为陈平和胡桔。公司公告汇总浙江圣达生物药业股份有限公司关于变更签字注册会计师的公告圣达生物2025年聘任致同会计师事务所为年度审计机构，原签字注册会计师刘志永、刘勇因内部工作调整，变更为陈平和胡桔。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603079","BK0191","BK0226"],"gpt_icon":0},{"id":"2595373651","title":"圣达生物（603079）披露关于变更签字注册会计师的公告，12月29日股价下跌1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595373651","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595373651?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:43","pubTimestamp":1767019394,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，圣达生物报收于16.76元，较前一交易日下跌1.3%，最新总市值为31.68亿元。公司近日发布公告称，浙江圣达生物药业股份有限公司于2025年聘任致同会计师事务所为公司年度审计机构。陈平自1999年成为注册会计师，2025年起为公司提供审计服务；胡桔自2019年成为注册会计师，2025年起在致同执业并为公司服务。本次变更不影响公司2025年度审计工作的正常进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","603079","BK0191"],"gpt_icon":0},{"id":"2594729882","title":"圣达生物（603079）披露使用闲置募集资金进行现金管理进展公告，12月26日股价下跌2.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594729882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594729882?lang=zh_cn&edition=full","pubTime":"2025-12-26 17:49","pubTimestamp":1766742553,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，圣达生物报收于16.98元，较前一交易日下跌2.13%，最新总市值为32.1亿元。公司近日发布公告称，浙江圣达生物药业股份有限公司使用闲置募集资金8,000.00万元购买中国建设银行浙江省分行单位人民币定制型结构性存款，产品期限31天，属于保本浮动收益型，不影响募投项目实施。最近12个月内累计使用闲置募集资金进行现金管理最高单日余额为18,000.00万元，尚余5,000.00万元额度未使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600026004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0226","603079"],"gpt_icon":0},{"id":"2594288685","title":"圣达生物（603079）1784.07万股限售股将于12月25日解禁，占总股本9.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594288685","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594288685?lang=zh_cn&edition=full","pubTime":"2025-12-25 08:12","pubTimestamp":1766621572,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，圣达生物于12月25日将有1784.07万股限售股份解禁，为公司定向增发机构配售股份，占公司总股本9.44%。本次解禁后，公司已无限售股份。圣达生物主营业务：长期致力于维生素、生物保鲜剂、食品添加剂和饲料添加剂的研发、生产和销售,并涉足功能配料领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500004458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0226","603079"],"gpt_icon":0},{"id":"2592904234","title":"圣达生物（603079）披露向特定对象发行股票限售股上市流通公告，12月18日股价上涨0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592904234?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:25","pubTimestamp":1766067953,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，圣达生物报收于16.41元，较前一交易日上涨0.31%，最新总市值为31.02亿元。公司近日发布公告称，浙江圣达生物药业股份有限公司向特定对象发行的17,840,666股限售股将于2025年12月25日起上市流通。本次发行新增股份于2025年6月25日完成登记，发行对象所持股份限售期为6个月。限售期满后，上述股份符合上市流通条件，无其他特别承诺。保荐机构中信建投证券对本次限售股上市流通无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800038828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","603079","BK0191"],"gpt_icon":0},{"id":"1194463260","title":"圣达生物宣布9.4%股份锁定期将结束，股票将于12月25日开始交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1194463260","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194463260?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:11","pubTimestamp":1766049070,"startTime":"0","endTime":"0","summary":"圣达生物宣布，公司9.4%股份的锁定期即将结束，相关股票将于12月25日开始交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0226","603079","BK0191"],"gpt_icon":0},{"id":"2590502880","title":"圣达生物（603079）披露使用闲置募集资金进行现金管理进展公告，12月12日股价下跌0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590502880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590502880?lang=zh_cn&edition=full","pubTime":"2025-12-12 22:17","pubTimestamp":1765549033,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘，圣达生物报收于16.8元，较前一交易日下跌0.3%，最新总市值为31.76亿元。该股当日开盘16.99元，最高17.16元，最低16.75元，成交额达4408.4万元，换手率为1.52%。最近12个月内累计使用闲置募集资金进行现金管理最高单日余额为18,000.00万元，尚余5,000.00万元额度未使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200041400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603079","BK0226","BK0191"],"gpt_icon":0},{"id":"2586225531","title":"圣达生物（603079）披露召开2025年第四次临时股东大会通知，11月27日股价上涨1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586225531","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586225531?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:19","pubTimestamp":1764253155,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，圣达生物报收于18.78元，较前一交易日上涨1.29%，最新总市值为35.5亿元。该股当日开盘18.54元，最高19.13元，最低18.52元，成交额达7932.96万元，换手率为2.46%。公司近日发布公告称，浙江圣达生物药业股份有限公司将于2025年12月15日召开2025年第四次临时股东大会，会议采用现场投票与网络投票相结合的方式，股权登记日为2025年12月10日。现场会议将于13点30分在浙江省天台县福溪街道始丰东路18号公司会议室召开。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603079","BK0226"],"gpt_icon":0},{"id":"2582186672","title":"每周股票复盘：圣达生物（603079）使用5000万元闲置募资购买结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2582186672","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582186672?lang=zh_cn&edition=full","pubTime":"2025-11-09 02:14","pubTimestamp":1762625652,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，圣达生物报收于20.88元，较上周的18.1元上涨15.36%。本周，圣达生物11月7日盘中最高价报21.55元，股价触及近一年最高点。本周关注点公司公告汇总：圣达生物使用5,000.00万元闲置募集资金购买建行结构性存款，预计年化收益率0.65%-1.90%。募集资金净额261,423,345.09元，用于年产20000吨D-异抗坏血酸及其钠盐项目，截至2025年9月30日累计投入进度14.30%。最近12个月已使用13,000.00万元进行现金管理，尚未收回本金13,000.00万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900000404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603079","BK0226"],"gpt_icon":0},{"id":"2581379089","title":"异动快报：圣达生物（603079）11月5日9点44分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2581379089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581379089?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:45","pubTimestamp":1762307146,"startTime":"0","endTime":"0","summary":"证券之星11月5日盘中消息，9点44分圣达生物触及涨停板。目前价格19.0，上涨3.49%。其所属行业化学制品目前下跌。领涨股为先锋新材。该股为维生素，化学原料药，医药概念热股，当日维生素概念上涨0.69%，化学原料药概念上涨0.47%，医药概念上涨0.38%。11月4日的资金流向数据方面，主力资金净流入818.39万元，占总成交额15.29%，游资资金净流入77.34万元，占总成交额1.45%，散户资金净流出895.74万元，占总成交额16.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500007811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603079","BK0226","BK0191"],"gpt_icon":0},{"id":"2580758999","title":"圣达生物（603079）披露使用闲置募集资金进行现金管理进展，11月04日股价上涨0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580758999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580758999?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:28","pubTimestamp":1762266507,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，圣达生物报收于18.36元，较前一交易日上涨0.05%，最新总市值为34.71亿元。近日，浙江圣达生物药业股份有限公司发布关于使用闲置募集资金进行现金管理的进展公告。公司使用额度不超过23,000.00万元的暂时闲置募集资金进行现金管理，资金可滚动使用，授权董事长签署相关文件。最近12个月已使用13,000.00万元进行现金管理，尚未收回本金13,000.00万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400039582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0226","603079"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771603215984,"stockEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0379},{"period":"3month","weight":-0.0411},{"period":"6month","weight":0.0554},{"period":"1year","weight":0.4373},{"period":"ytd","weight":0.1185}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江圣达生物药业股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"13391人(较上一季度减少23.86%)","perCapita":"14116股","listingDate":"2017-08-23","address":"浙江省台州市天台县赤城街道人民东路789号","registeredCapital":"18902万元","survey":" 浙江圣达生物药业股份有限公司的主营业务是维生素、生物保鲜剂、食品添加剂和饲料添加剂的研发、生产和销售，并涉足功能配料领域。公司的主要产品是生物素、叶酸等维生素类产品和乳酸链球菌素、纳他霉素、聚赖氨酸、蔗糖发酵物等生物保鲜剂及功能配料产品。","listedPrice":15.09},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣达生物(603079)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣达生物(603079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣达生物,603079,圣达生物股票,圣达生物股票老虎,圣达生物股票老虎国际,圣达生物行情,圣达生物股票行情,圣达生物股价,圣达生物股市,圣达生物股票价格,圣达生物股票交易,圣达生物股票购买,圣达生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣达生物(603079)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣达生物(603079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}